Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuberg Center for Genomic Medicine (NCGM) is a genomics-focused diagnostics and research services business affiliated with Neuberg Diagnostics, offering cytogenetic, molecular diagnostic, and sequencing-based services for clinical and research use. The organization operates major genomic testing activities from Ahmedabad, India, and Apex, North Carolina, and positions itself as a one-stop provider for inherited disease testing, reproductive genetics, oncology genomics, pharmacogenomics, transplant immunology, and research sequencing services. Its service portfolio includes DNA sequencing, RNA sequencing, epigenetics, metagenomics, single-cell genomics, long-read sequencing, and genetic counseling. Rather than developing therapeutic drugs, NCGM functions as a commercial laboratory and genomics services platform serving healthcare providers, researchers, and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuberg Center for Genomic Medicine.